These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1902610)

  • 1. Unresponsiveness of vaccinated BALB/c mice to a second inoculation of lipopolysaccharide from Brucella abortus strain 2308.
    Pugh GW; Phillips M; Tabatabai LB; McDonald TJ
    Vet Microbiol; 1991 Jan; 26(1-2):167-77. PubMed ID: 1902610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monophosphoryl lipid A-induced immune enhancement of Brucella abortus salt-extractable protein and lipopolysaccharide vaccines in BALB/c mice.
    Tabatabai LB; Pugh GW; Stevens MG; Phillips M; McDonald TJ
    Am J Vet Res; 1992 Oct; 53(10):1900-7. PubMed ID: 1456539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of strain 2308 infection and immunogenicity of Brucella abortus lipopolysaccharide in five strains of mice.
    Phillips M; Pugh GW; Deyoe BL
    Am J Vet Res; 1989 Mar; 50(3):318-22. PubMed ID: 2494912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic, histopathologic, and bacteriologic responses of five strains of mice to Brucella abortus strain 2308.
    Pugh GW; Zehr ES; Meador VP; Phillips M; McDonald TJ; Deyoe BL
    Am J Vet Res; 1989 Mar; 50(3):323-8. PubMed ID: 2494913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of dose-response relationships in BALB/c mice, using Brucella cell surface protein and lipopolysaccharide.
    Pugh GW; Tabatabai LB; Phillips M; McDonald TJ
    Am J Vet Res; 1991 Feb; 52(2):261-8. PubMed ID: 1901465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses and resistance to brucellosis in mice vaccinated orally with Brucella abortus RB51.
    Stevens MG; Olsen SC; Palmer MV; Pugh GW
    Infect Immun; 1996 Nov; 64(11):4534-41. PubMed ID: 8890203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Brucella abortus transfer factor in preventing murine brucellosis.
    Stevens MG; Pugh GW
    FEMS Immunol Med Microbiol; 1995 Jul; 11(4):279-84. PubMed ID: 8541805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51.
    Stevens MG; Olsen SC; Pugh GW; Brees D
    Infect Immun; 1995 Jan; 63(1):264-70. PubMed ID: 7806364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
    Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of serum bactericidal and splenic activity of Total-OMP- CagA combination from Brucella abortus and Helicobacter pylori in BALB/c mouse model.
    Abadi AH; Mahdavi M; Khaledi A; Esmaeili SA; Esmaeili D; Sahebkar A
    Microb Pathog; 2018 Aug; 121():100-105. PubMed ID: 29709690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
    Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of mice against Brucella abortus by immunization with polyclonal anti-idiotype antibodies.
    Beauclair KD; Khansari DN
    Immunobiology; 1990 Feb; 180(2-3):208-20. PubMed ID: 2111796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.
    Kahl-McDonagh MM; Arenas-Gamboa AM; Ficht TA
    Infect Immun; 2007 Oct; 75(10):4923-32. PubMed ID: 17664263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice.
    Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H
    Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of BALB/C mice against Brucella abortus 544 challenge by vaccination with combination of recombinant human serum albumin-l7/l12 (Brucella abortus ribosomal protein) and lipopolysaccharide.
    Pakzad I; Rezaee A; Rasaee MJ; Hossieni AZ; Tabbaraee B; Kazemnejad A
    Roum Arch Microbiol Immunol; 2010; 69(1):5-12. PubMed ID: 21053778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity.
    Sáez D; Fernández P; Rivera A; Andrews E; Oñate A
    Vaccine; 2012 Feb; 30(7):1283-90. PubMed ID: 22222868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brucella abortus ΔrpoE1 confers protective immunity against wild type challenge in a mouse model of brucellosis.
    Willett JW; Herrou J; Czyz DM; Cheng JX; Crosson S
    Vaccine; 2016 Sep; 34(42):5073-5081. PubMed ID: 27591954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.